AI Verdict
MDB has stronger fundamentals based on our AI analysis.
MDCXW vs MDB Fundamental Comparison
| Metric | MDCXW | MDB |
|---|---|---|
| Revenue | $-197,382.0 | $2.5B |
| Net Income | $-47.3M | $-71.2M |
| Net Margin | 23,954.3% | -2.9% |
| ROE | N/A | -2.4% |
| ROA | -469.9% | -1.9% |
| Current Ratio | 1.00x | 4.65x |
| Debt/Equity | N/A | 0.07x |
| EPS | $-2.74 | $-0.88 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MDCXW vs MDB: Frequently Asked Questions
Is MDCXW or MDB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MDB has stronger fundamentals. MDCXW is rated STRONG SELL (95% confidence) while MDB is rated HOLD (62% confidence). This is not investment advice.
How does MDCXW compare to MDB fundamentally?
Medicus Pharma Ltd. has ROE of N/A vs MongoDB, Inc.'s -2.4%. Net margins are 23,954.3% vs -2.9% respectively.
Which stock pays higher dividends, MDCXW or MDB?
MDCXW has a dividend yield of N/A or no dividend while MDB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MDCXW or MDB for long term?
For long-term investing, consider that MDCXW has STRONG SELL rating with 95% confidence, while MDB has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MDCXW vs MDB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDCXW vs MDB, the AI consensus favors MDB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.